168
Views
30
CrossRef citations to date
0
Altmetric
CHROMATOGRAPHY

Rapid and Highly Sensitive HPLC and TLC Methods for Quantitation of Amlodipine Besilate and Valsartan in Bulk Powder and in Pharmaceutical Dosage Forms and in Human Plasma

, &
Pages 570-581 | Received 26 Mar 2009, Accepted 08 Aug 2009, Published online: 08 Feb 2010
 

Abstract

Two simple, sensitive, and specific high-performance liquid chromatography and thin-layer chromatography methods were developed for the simultaneous estimation of Amlodipine besilate (AM) and Valsartan (VL). Separation by HPLC was achieved using a xTerra C18 column and methanol /acetonitrile /water/ 0.05% triethylamine in a ratio 40:20:30:10 by volume as mobile phase, pH was adjusted to 3 ± 0.1 with o-phosphoric acid. The flow rate was 1.2 mL min−1. The linearity range was 0.2 to 2 µg mL−1 for amlodipine besilate and 0.4 to 4 µg mL−1 for Valsartan with a mean percentage recovery of 99.59 ± 0.523% and 100.61 ± 0.400% for amlodipine besilate and valsartan, respectively. The TLC method used silica gel 60 F254 plates; the optimized mobile phase was ethyl acetate/ methanol / ammonium hydroxide (55:45:5 by volume). Quantitatively, the spots were scanned densitometrically at 237 nm. The range was 0.5–4.0 µg spot−1 for amlodipine besilate and 2.0–12.0 µg spot−1 for valsartan. The mean percentages recovery was 99.80 ± 0.451% and 100.61 ± 0.363% for amlodipine besilate and valsartan, respectively. The HPLC method was found to be simple, selective, precise, and reproducible for the estimation of both drugs from spiked human plasma.

Notes

*The parameters were calculated using AM and VL as references.

equations obtained by the proposed methods.

a Results of five determinations.

b n = 3 × 3.

c n = 3 × 3.

Figures in parentheses are the corresponding tabulated values at p = 0.05.

(3)HPLC method using (acetonitrile: methanol: solution of 7 ml triethylamine in a liter of water, pH 3 with phosphoric acid 15:35:50 by volume).

(13)HPLC method using (0.02 M phosphate buffer pH 3.2:acetonitrile 55:45 v/v).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.